Editorial Policies

Focus and Scope

The Canadian Oncology Nursing Journal is the official publication of the Canadian Association of Nurses in Oncology and is directed to the professional nurse caring for patients and families with cancer. The journal supports the philosophy of the national association. It is an open access publication to enable a wide readership.

The purpose of the journal is to support and stimulate the development and growth of oncology nursing practice, education research, and leadership in Canada. The specific objectives are to:

  • Disseminate current cancer control knowledge to underpin the specialty practice of oncology nurses and the nursing care of cancer patients in general
  • Publish a high quality bilingual (English and French) journal
  • Include a mix of peer reviewed and invited manuscripts
  • Foster the capacity of oncology nurses to publish in a professional journal

The journal acts as a vehicle for sharing evidence related to clinical oncology practice, technology, education, research, and leadership. In addition, the journal serves to keep Canadian oncology nurses appraised regarding the significant developments from their national specialty association.

The Strategic Direction for the publication is to grow the Canadian Oncology Nursing Journal as the vehicle to promote the growth and development of the oncology nursing specialty in Canada. The Journal welcomes submissions from both within and beyond Canada.


Section Policies


Checked Open Submissions Unchecked Indexed Unchecked Peer Reviewed


Checked Open Submissions Checked Indexed Checked Peer Reviewed


Checked Open Submissions Checked Indexed Unchecked Peer Reviewed


Checked Open Submissions Checked Indexed Unchecked Peer Reviewed


Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Conference Abstracts

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Conference Poster Abstracts

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Peer Review Process

All manuscripts submitted to the Canadian Oncology Nursing Journal undergo double-blind, external review, unless they are out of scope for the Journal or were submitted as a Feature (See below).

A manuscript submitted to the CONJ for possible publication must be submitted to CONJ alone (i.e., must not be submitted to another journal at the same time) and must not have been published, submitted or accepted for publication elsewhere.

When a manuscript is submitted, it is expected that one author will be named corresponding author and all correspondence or communication about the manuscript will be with this individual. Manuscripts submitted to the Journal will be acknowledged as received.

Upon submission, the Editor in Chief will review the manuscript and determine its suitability for the journal and the adherence to the Journal guidelines. If either of these criteria are not met, the manuscript will be return to the corresponding author with a note of explanation within a week.

All manuscripts submitted for peer-review are reviewed by at least two suitably qualitied experts selected by the Editor in Chief. Reviewers are asked to identify any conflicts or competing interests prior to accepting the invitation to review a manuscript.

Reviewer comments are returned to the Editor in Chief who makes the final publication decisions based on these reviews. The review process is a confidential communication between the reviewers and the Editor in Chief, and subsequently between the Editor in Chief and the corresponding author. Reviewers are instructed not to discuss any manuscript they receive for review from the Editor in Chief with anyone not involved directly in the review of the specific manuscript.

Submissions deemed suitable for peer review by the Canadian Oncology Nursing Journal are sent to at least two experts selected by the Editor in Chief. Selection, at the sole discretion of the Editor in Chief, is based on the nature of the topic and the type of manuscript as well as no conflict of interest. The Journal uses a double-blind review process where neither the reviewers nor the author are aware of one another’s identity.

The reviewers utilize the Journal Reviewer Feedback Form to return their comments to the Editor in Chief. These comments are collated by the Editor in Chief and sent back to the corresponding author of a manuscript together with the indication about the status of the manuscript (i.e., acceptance, rejection, amendments in the manuscript). This review process is expected to take approximately 4-6 weeks.

For manuscripts that are revised and returned to the Editor in Chief, it is expected the authors will also submit a point-by-point response to the reviewers’ comments. Manuscripts that have undergone a major revision will likely be sent to external reviewers for a new review. However, those requiring only minor revisions will be reviewed on resubmission by the Editor in Chief.

Manuscripts that are accepted for publication are copy edited for grammar, punctuation, print style, and format. They are subsequently translated from English to French or from French to English. Any questions that require author input during the translation process will be handled through the corresponding author.

Once publication layout has been completed, page proofs will be sent to the corresponding author for review. The corresponding author is expected to return corrected proofs within three days. It may not be possible to incorporate changes if the designated time period is exceeded.

The entire process of submission to final decision, and the sending and receiving proofs, is completed online.

Manuscripts submitted for consideration as a Feature Article will be reviewed by the Editor in Chief. Feedback regarding the manuscript will be provided by the Editor in Chief to the corresponding author. Feedback will include indication of the publication status (i.e., acceptance, rejection, amendments). The final decision regarding publication will be at the sole discretion of the Editor in Chief. Once the manuscript is accepted for publication, the process for copy editing and translation will be followed as described above.  


Publication Frequency

The journal is published quarterly in February, May, August and November.


Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.



This journal utilizes the LOCKSS system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration. More...


Editorial Board

Karine Bilodeau, inf., Ph.D., Professeure adjointe, Faculté des science infirmières, Université de Montréal, 2375, chemin Côte-Ste-Catherine, bureau 7101, Montréal, QC, H3T 1A8; Tél. : 514-343-6111, poste 43254, karine.bilodeau.2@umontreal.ca

Janice Chobanuk, RN, BSc, MN, CON(C), Clinical Leader Community Oncology, Alberta Health Services, Cancer Care Community Oncology, 1500 10123 99 Street, Edmonton, AB T5J 3H1, 780-643-4542; fax: 780-643-4542; janice.chobanuk@healthservices.ca

Manon Lemonde, IA, PhD, Professeure agrégée, Faculty of Health Sciences, University of Ontario Institute of Technology; Manon.Lemonde@uoit.ca

Dawn Stacey, RN, PhD, University of Ottawa, School of Nursing, 451 Smyth Road (Rm 1118), Ottawa, ON K1H 8M5; dawn.stacey@uottawa.ca

Fay J. Strohschein, RN, PhD(c), Ingram School of Nursing, McGill University, Nursing Counsellor, Geriatric Oncology, Jewish General Hospital, Montréal, QC, 514-340-8222, ext. 3864; Fay.strohschein@mail.mcgill.ca

Sally Thorne, RN, PhD, FCAHS, University of British Columbia, T201-2211 Wesbrook Mall, Vancouver, BC V6T 2B5 604-822-7482; sally.thorne@nursing.ubc.ca


Managing Editor

Heather Coughlin, 613-633-1938, e-mail: heather@pappin.com



The Canadian Oncology Nursing Journal is produced in conjunction with Pappin Communications, 1012 Snake River Line, Cobden, ON K0J 1K0, phone: 613-633-1938, e-mail heather@pappin.com



The Canadian Oncology Nursing Journal/Revue canadienne de soins infirmiers en oncologie is registered with the National Library of Canada, ISSN 2368-8076, and is indexed in the Cumulative Index to Nursing and Allied Health Literature, (CINAHL), the International Nursing Index and Medline.



All nurses with active Canadian registration are eligible for membership in CANO. Contact the CANO national office. Refer to the Communiqué section for name and contact information of provincial representatives.


Author Information

Guidelines for authors are usually included in each issue. All submissions are welcome. At least one author should be a registered nurse, however, the editor has final discretion on suitability for inclusion. Author(s) are responsible for acknowledging all sources of funding and/or information.

How to submit your manuscript online:

  1. Complete the submission preparation checklist
  2. Register an account
  3. Login
  4. Click on Author
  5. Click on New Submission
  6. Complete the 5 step submission process


Language Policy/Politique linguistique

The Canadian Oncology Nursing Journal is officially a bilingual publication. All journal content submitted and reviewed by the editors will be printed in both official languages. La Revue canadienne de soins infirmiers en oncologie est une publication officiellement bilingue. Le contenu proprement dit de la Revue qui est soumis et fait l’objet d’une évaluation par les rédactrices est publié dans les deux langues officielles.



For general advertising information and rates, contact Heather Coughlin, Advertising Manager, 1012 Snake River Line, Cobden, ON K0J 1K0, 613-633-1938, e-mail heather@pappin.com. All advertising correspondence and material should be sent to Pappin Communications. Online rate card available at: www.pappin.com


Licensing and reprint permissions

Copyright of the articles printed in the Canadian Oncology Nursing Journal (CONJ) is owned by the journal. CONJ grants permission for individuals to use figures, tables, and short quotes from the CONJ for republication in academic works and to make single copies for personal use in research, study, or teaching provided full attribution is included. There is no need to request this permission from CONJ.

CONJ also encourages linking to this content directly. Journal content since 1991 is now available in open access format at http://www.canadianoncologynursingjournal.com

This permission does not extend to public posting of the PDF or HTML created by CONJ for publication or to reproduction of such.

If you would like to print copies to distribute to others, reproduce the article on your own website, include it in your marketing materials, or make some other use of our content, you have to ask our permission. Permission to reproduce is granted under the condition that no editorial changes will be made (deletions, additions, changes in wording).

Please email the URL of the article you wish to reprint to heather@pappin.com

Fees apply for copyright permission

Standard reprints

Standard commercial reprints are an exact replica of the published article. All CONJ reprints are supplied with a cover, and printed double-sided on offset text paper, corner stitched.

The administrative and print management fee is $95.00 per article (English and French of the same article are considered as two).

Print and shipping costs are dependent on the length of the article and quantity required and will be quoted at the time of request.

File only

Print ready files will be provided in the case that printing and shipping by CONJ are not feasible. Permission will be given to reproduce only the pre-arranged quantity of copies and these are not to be for resale.

The administrative/copyright fee is $125.00 per article (English and French of the same article are considered as two).

Download the Reprint permissions form here.



Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License


Online Advertising Policy

  1. All advertisements are subject to approval of the Publisher, Editor, or Canadian Association of Oncology Nursing, which reserves the right to reject or cancel any advertisement at any time.
  2. Advertising is separate from content. Advertisers and sponsors have no advance knowledge of our editorial content, nor do the editors shape content to accommodate advertising. Publisher will not sell advertising for a specific product on the condition that it appear in the same location, and at the same time, as a specific article mentioning that product, unless clearly labeled as an exclusive sponsor. Advertisers do not influence any of our editorial decisions or advertising policies. 
  3. The appearance of advertising is neither a guarantee nor an endorsement by the publisher, society or editorial partner of the product, service, or company and claims made in such advertising.
  4. Advertising that appears on Publisher’s website and in email service will be clearly distinguishable from editorial content. 
  5. Banner advertising is not sold or purchased based on editorial adjacency. Ads are delivered randomly throughout the site and constantly change; therefore, the adjacency of an advertisement to editorial mention of product or category can occur inadvertently and infrequently. 
  6. Publisher’s advertising sales representatives have neither control over, nor prior knowledge of, specific editorial content before it is published. 
  7. Advertisers have no control or influence over the results of searches a user may conduct on the Publisher’s website. Search results are based solely on the functionality available through our search software (e.g., keywords or natural language) and user-defined criteria (e.g., displaying most recent or most relevant items first)
  8. All advertisements are accepted and published by Publisher on the warranty of the agency and advertiser that both are authorized to publish the entire contents and subject matter of the advertisement. 
  9. In consideration of publication of an advertisement, the advertiser and the agency, jointly and severally, agree to indemnify and hold harmless Publisher, its officers, agents and employees against expenses (including legal fees) and losses resulting from the publication of the contents of the advertisement, including, without limitation, claims or suits for libel, violation of privacy, copyright infringement or plagiarism. 
  10. Publisher shall not be liable for any failure to publish any advertisement accepted by Publisher; however, Publisher shall use its reasonable efforts to place such advertisement in subsequent available space.
  11. All advertisements must clearly and prominently identify the advertiser by trademark or signature. 
  12. Any reference to Publisher or it products or services in advertisements, promotional material, or merchandising by the advertiser or the agency is subject to the Publisher’s prior written approval for each such use. 
  13. All advertising contract position clauses are treated as requests. Since advertising inventory constantly changes, Publisher cannot guarantee fixed positioning, unless otherwise indicated as exclusive sponsorship. 
  14. Publisher is not responsible for any damages, including but not limited to actual, direct, incidental or consequential damages, for errors in displaying an ad. 
  15. Publisher may change the terms set forth herein at any time, provided that no such change applies to ads whose closing date precedes the announcement of the change. 
  16. Publisher will not be bound by any condition, printed or otherwise, appearing on any insertion order or copy instructions when such conditions conflict with the conditions set forth in this policy statement. 
  17. In the event of nonpayment, Publisher reserves the right to hold advertiser and/or its advertising agency liable for such monies as are due and payable to CANO. 
  18. Any use of Publication trademarks or copyrighted material for links to and from the website must be approved, in advance, by the Publisher. Any such unauthorized linking is prohibited.
  19. The Publisher does not endorse or support any product or organization linked to the Journal’s website nor is the Publisher responsible for the content of any website promoted in an advertisement published in the Journal. 
  20. Recruitment ads: All advertisements for employment must be nondiscriminatory and comply with all applicable laws and regulations. Ads that discriminate against applicants based on sex, age, race, religion, marital status, or physical handicap will not be accepted. Non-US recruitment advertisers are required to confirm in writing that they are equal opportunity employers. 
  21. Advertised products must be compliant with the regulations in the country where the advertisement will be seen. Advertisements for pharmaceutical products must comply with regulations regarding advertising and promotion (i.e., PAAB). 
  22. Advertiser links to other websites cannot prevent a user from easily returning to Publisher’s website. 
  23. Publisher does not release personally identifiable data on the users of our websites or email service to advertisers. 



When reporting studies on human beings, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 2000 (available at http://www.wma.net/e/policy/17-c_e.html). For prospective studies involving human participants, authors are expected to mention about approval of (regional/ national/ institutional or independent Ethics Committee or Review Board, obtaining informed consent from adult research participants and obtaining assent for children aged over 7 years participating in the trial. The age beyond which assent would be required could vary as per regional and/ or national guidelines. Ensure confidentiality of subjects by desisting from mentioning participants’ names, initials or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institution’s or a national research council’s guide for, or any national law on the care and use of laboratory animals was followed.


Editorial Process

Manuscripts can be submitted for two types of publications or sections with the Journal: peer-reviewed publications and ‘feature’ publications. The latter are shorter submissions (500-1200 words) focusing on reflections about clinical practice, media reviews, letters to the editor, quality improvement or program initiatives and pilot/feasibility projects, and will be reviewed and published at the discretion of the Editor in Chief. Peer reviewed manuscripts are lengthy manuscripts (6-16 pages) describing original work, or research study results, and will undergo a formal peer review process.


Authorship Criteria

Authorship credit should be based on having made a substantial contribution to each of the three aspects listed below:

  1. Concept and design of a study or program, gathering/analysis of data, interpretation of data,
  2. Drafting the article or revising it critically for important intellectual content, and
  3. Final approval of the version to be published.

Each contributor should have participated sufficiently in the work to take public responsibility for appropriate portions of the content of the manuscript. The order of naming the contributors should be based on the relative contribution of the contributor towards the study and writing the manuscript. Once submitted the order cannot be changed without written consent of all the contributors


Conflicts of interest/competing interests

All authors must disclose any and all conflicts of interest that they may have with publication of the manuscript or an institution or product that is mentioned in the manuscript and/or is important to the outcome of the work. Authors should also declare any conflict of interest they have with products that compete with the ones mentioned in their manuscript.